A Longitudinal Retrospective Case Series of the Real-World Toxicities Encountered among Cancer Patients Receiving Anti-Pd-l1 Checkpoint Inhibitor Immunotherapy.

Anastasios L. Boutis, Aglaia Skolariki,Nikolaos Diamantopoulos,Alexandros Bokas, Georgios Chatsidis, Georgios Rizos,Pavlos Papakotoulas

Journal of clinical oncology（2018）

引用 0|浏览24

暂无评分

摘要

e15117Background: Immunotherapy with anti-PD-L1 immune checkpoint inhibitors is currently a major component of systemic therapy in advanced solid tumors. Their toxicity profile has been well establ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要